Jean F. Voltaire

Array ( [id] => 5552836 [patent_doc_number] => 20090286822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Treatment of psoriasis and of other skin disorders associated with inhibition of differentiation of epidermal cells' [patent_app_type] => utility [patent_app_number] => 12/460620 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9342 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286822.pdf [firstpage_image] =>[orig_patent_app_number] => 12460620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555277 [patent_doc_number] => 08329749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia' [patent_app_type] => utility [patent_app_number] => 12/504061 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 24286 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496035 [patent_doc_number] => 20100093853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA' [patent_app_type] => utility [patent_app_number] => 12/504487 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16553 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093853.pdf [firstpage_image] =>[orig_patent_app_number] => 12504487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682255 [patent_doc_number] => 20100022553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Therapeutic Combination Comprising an Aurora Kinase Inhibitor and Imatinib' [patent_app_type] => utility [patent_app_number] => 12/503729 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3216 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022553.pdf [firstpage_image] =>[orig_patent_app_number] => 12503729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629176 [patent_doc_number] => 20100004257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Identification of Biomarkers Predictive of Dasatinib Effects in Cancer Cells' [patent_app_type] => utility [patent_app_number] => 12/501897 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15441 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004257.pdf [firstpage_image] =>[orig_patent_app_number] => 12501897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973015 [patent_doc_number] => 20110152317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'PREVENNTING THE OCCURRENCE OF OBESITY' [patent_app_type] => utility [patent_app_number] => 12/996654 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1399 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152317.pdf [firstpage_image] =>[orig_patent_app_number] => 12996654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615401 [patent_doc_number] => 20100003192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'TREATMENT OF BREAST CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTI-TUMOR AGENTS' [patent_app_type] => utility [patent_app_number] => 12/496593 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44330 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003192.pdf [firstpage_image] =>[orig_patent_app_number] => 12496593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374799 [patent_doc_number] => 20090312360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Antineoplastic Combinations Containing HKI-272 and Vinorelbine' [patent_app_type] => utility [patent_app_number] => 12/486153 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11800 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312360.pdf [firstpage_image] =>[orig_patent_app_number] => 12486153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547616 [patent_doc_number] => 20100016421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'METHODS FOR DETERMINING SENSITIVITY TO AMINOFLAVONES' [patent_app_type] => utility [patent_app_number] => 12/485695 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6602 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016421.pdf [firstpage_image] =>[orig_patent_app_number] => 12485695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304138 [patent_doc_number] => 20090298790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'NOVEL THERAPEUTIC USE FOR TREATING OF LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 12/485401 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4540 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298790.pdf [firstpage_image] =>[orig_patent_app_number] => 12485401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000971 [patent_doc_number] => 20110117219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'HAIR TREATMENT PRODUCT AND HAIR AFTER-TREATMENT PRODUCT CONTAINING ETHER GUANIDINES AS ACTIVE SUBSTANCES, FOR PROTECTING FROM DAMAGE CAUSED BY CHEMICAL TREATMENT AND FOR REPAIRING ALREADY DAMAGED HAIR' [patent_app_type] => utility [patent_app_number] => 13/001562 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15784 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117219.pdf [firstpage_image] =>[orig_patent_app_number] => 13001562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386363 [patent_doc_number] => 20090227608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'USE OF C-SRC INHIBITORS ALONE OR IN COMBINATION WITH STI571 FOR THE TREATMENT OF LEUKAEMIA' [patent_app_type] => utility [patent_app_number] => 12/466186 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3621 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227608.pdf [firstpage_image] =>[orig_patent_app_number] => 12466186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368475 [patent_doc_number] => 20090306034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'USE OF PICOPLATIN TO TREAT COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/465563 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7961 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306034.pdf [firstpage_image] =>[orig_patent_app_number] => 12465563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483928 [patent_doc_number] => 20120283335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Analogs of Propofol, Preparation Thereof and Use as Anesthetics' [patent_app_type] => utility [patent_app_number] => 12/990486 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8210 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152219 [patent_doc_number] => 08168661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Use of picoplatin to treat colorectal cancer' [patent_app_type] => utility [patent_app_number] => 12/464662 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7446 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168661.pdf [firstpage_image] =>[orig_patent_app_number] => 12464662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515530 [patent_doc_number] => 20090215837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'ADMINISTRATION OF PYRIDINEDICARBOXYLIC ACID COMPOUNDS FOR STIMULATING OR INDUCING THE GROWTH OF HUMAN KERATINOUS FIBERS AND/OR ARRESTING THEIR LOSS' [patent_app_type] => utility [patent_app_number] => 12/463602 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6257 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215837.pdf [firstpage_image] =>[orig_patent_app_number] => 12463602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473006 [patent_doc_number] => 20090246172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'COMPOSITIONS COMPRISING EPOTHILONES AND THEIR USE FOR THE TREATMENT OF CARCINOID SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/437226 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4355 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246172.pdf [firstpage_image] =>[orig_patent_app_number] => 12437226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273622 [patent_doc_number] => 08637554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Methods for treating thyroid cancer' [patent_app_type] => utility [patent_app_number] => 12/436957 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 22953 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12436957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977738 [patent_doc_number] => 20110071100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'SULFOBETAINES FOR CANCER, OBESITY, MACULAR DEGENERATION, NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/990971 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9621 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071100.pdf [firstpage_image] =>[orig_patent_app_number] => 12990971 [rel_patent_id] =>[rel_patent_doc_number] =>)